Phenyl lactic acid alleviatesHelicobacter pyloriinfection in C57BL/6 mice
- 22 March 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (11), 5032-5047
- https://doi.org/10.1039/d3fo00099k
Abstract
Helicobacter pylori is a gastric pathogen that colonizes approximately 50% of the world's population. Infection with H. pylori causes chronic inflammation and significantly increases the risk of developing duodenal and gastric ulcer disease and gastric cancer. In the present study, we found that phenyl lactic acid (PLA) derived from Lactobacillus plantarum ZJ316 (L. plantarum ZJ316) can directly inhibit the growth and urease activity of H. pylori in vitro with a minimum inhibitory concentration (MIC) of 2.5 mg mL−1. Moreover, PLA also caused a dramatic morphological transformation from a spiral to a coccoid form in H. pylori. In this work, we also analyzed the beneficial effects of PLA in mice. The results showed that PLA administration ameliorated H. pylori-induced gastric mucosal damage and significantly decreased lymphocyte infiltration and inflammatory cytokines, including interleukin-1β (IL-1β), interleukin 6 (IL-6), and interferon-γ (IFN-γ) by 59.93%, 63.95%, and 48.05%, respectively, but elevated the interleukin-10 (IL-10) and glutathione (GSH) levels. Furthermore, PLA administration improved microbiota diversity with increased Bacteroidetes abundance and decreased Proteobacteria abundance by 46.39% and 24.05%, respectively. PLA also significantly reduced the abundance of H. pylori but increased the relative abundances of potential beneficial bacteria, such as Faecalibacterium, Bifidobacterium, and Lactobacillus. These results demonstrated that PLA can ameliorate H. pylori-induced inflammation and support beneficial gut bacteria, providing a new perspective against H. pylori infection.Funding Information
- Natural Science Foundation of Zhejiang Province (LZ21C200001, LY22C200012)
- National Natural Science Foundation of China (32001667)
This publication has 95 references indexed in Scilit:
- Treatment of Helicobacter pylori Infection 2013Helicobacter, 2013
- Isolation of Lactococcus lactis Mutants Simultaneously Resistant to the Cell Wall-Active Bacteriocin Lcn972, Lysozyme, Nisin, and Bacteriophage c2Applied and Environmental Microbiology, 2012
- Probiotic Mechanism of Lactobacillus gasseri OLL2716 Strain against Helicobacter pyloriJournal of Clinical Microbiology, 2012
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trialThe Lancet, 2011
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Helicobacter pylori treatment in the era of increasing antibiotic resistanceGut, 2010
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- Developmental biology of gut-probiotic interactionGut Microbes, 2010
- Helicobacter pylori infection: approach of primary care physicians in a developing countryBMC Gastroenterology, 2009
- Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cellsBMC Cancer, 2009